IMC Chicago’s Inovio Pharmaceuticals INO Stock Holding History

IMC Chicago’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-17,200	Closed	-$239K	–	2694
2024 Q1	$239K	Buy	+17,200	New	+$148K	﹤0.01%	2291
2023 Q1	–	Sell	-19,308	Closed	-$361K	–	1328
2022 Q4	$361K	Buy	19,308 +7,791	+68%	+$177K	﹤0.01%	1181
2022 Q3	$238K	Buy	+11,517	New	+$295K	﹤0.01%	1174
2022 Q2	–	Sell	-4,650	Closed	-$200K	–	1098
2022 Q1	$200K	Sell	4,650 -20,325	-81%	-$916K	﹤0.01%	1070
2021 Q4	$1.5M	Sell	24,975 -2,292	-8%	-$184K	﹤0.01%	884
2021 Q3	$2.34M	Sell	27,267 -2,541	-9%	-$255K	﹤0.01%	808
2021 Q2	$3.32M	Sell	29,808 -12,109	-29%	-$1.16M	﹤0.01%	670
2021 Q1	$4.67M	Buy	41,917 +867	+2%	+$114K	0.01%	585
2020 Q4	$4.36M	Sell	41,050 -18,075	-31%	-$2.41M	0.01%	578
2020 Q3	$8.23M	Buy	59,125 +31,608	+115%	+$6.59M	0.01%	338
2020 Q2	$8.9M	Buy	+27,517	New	+$4.42M	0.02%	278

Other funds holding INO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IMC Chicago's INO Position: Q1 2026 in Review

IMC Chicago opened a new position in Inovio Pharmaceuticals (INO) in Q1 2026: 37,889 shares worth $65.9K. The stake represents ﹤0.01% of the portfolio and ranks #5461 among its holdings. This is a return to the name: IMC Chicago previously reported a position in INO as recently as Q4 2020.

IMC Chicago first reported a position in INO in Q2 2020 and has held it in 3 quarters since. The position peaked at $719K in Q2 2020. 100 funds tracked by Wall St. Rank hold INO as of Q1 2026.

IMC Chicago held 37,889 shares of Inovio Pharmaceuticals worth $65.9K as of Q1 2026.
Inovio Pharmaceuticals was a new IMC Chicago position in Q1 2026.
Inovio Pharmaceuticals made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #5461 holding.
IMC Chicago first reported a position in Inovio Pharmaceuticals in Q2 2020 and has held it in 3 quarters since.
IMC Chicago's Inovio Pharmaceuticals position peaked at $719K in Q2 2020.
100 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.